Aehr Test Systems (NASDAQ: AEHR) raises $60.0M via at-the-market stock sales
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Aehr Test Systems completed sales under its at-the-market equity offering program, generating aggregate gross proceeds of approximately $60.0 million from common stock issuances. The shares were sold under an effective Form S-3 shelf registration that registered up to $100.0 million of securities, using a prospectus supplement dated April 8, 2026.
Positive
- None.
Negative
- None.
Insights
Aehr Test Systems completes $60.0M at-the-market stock sales.
Aehr Test Systems has fully utilized its at-the-market equity offering program, selling common stock for aggregate gross proceeds of $60.0 million. These sales were made under an effective Form S-3 shelf registration that permitted issuance of up to $100.0 million of securities.
The completed at-the-market program provides additional equity capital, with pricing and exact issuance timing not detailed in the excerpt. The shares were issued pursuant to a prospectus supplement dated April 8, 2026, indicating a recently executed capital raise using an established shelf framework.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM gross proceeds: $60.0 million
Shelf registration capacity: $100.0 million
Prospectus supplement date: April 8, 2026
+1 more
4 metrics
ATM gross proceeds
$60.0 million
Aggregate gross proceeds from common stock sales under at-the-market program
Shelf registration capacity
$100.0 million
Total securities registered on Form S-3 (File No. 333-282661)
Prospectus supplement date
April 8, 2026
Date of prospectus supplement used for at-the-market sales
Other event date
April 17, 2026
Date the company fully utilized its at-the-market offering program
Key Terms
at-the-market equity offering program, Form S-3, registration statement, prospectus supplement
4 terms
at-the-market equity offering program financial
"fully utilized its previously announced at-the-market equity offering program"
A program that lets a company sell newly issued shares directly into the open market at whatever the current trading price is, usually through a broker, and do so gradually over time instead of all at once. Investors care because it can dilute existing ownership and put steady selling pressure on the stock price, while giving the company a flexible, on-demand way to raise cash — like adding small amounts of water to a pool rather than dumping in a bucket.
Form S-3 regulatory
"effective registration statement on Form S-3 (File No. 333-282661)"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
registration statement regulatory
"effective registration statement on Form S-3 (File No. 333-282661)"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
prospectus supplement financial
"and the prospectus supplement dated April 8, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
FAQ
What did Aehr Test Systems (AEHR) announce in this 8-K filing?
Aehr Test Systems announced it fully utilized its at-the-market equity offering program, selling common stock for aggregate gross proceeds of approximately $60.0 million. These sales were completed under an effective Form S-3 shelf registration and a prospectus supplement dated April 8, 2026.
How much capital did Aehr Test Systems (AEHR) raise through its at-the-market program?
Aehr Test Systems raised aggregate gross proceeds of approximately $60.0 million by selling shares of its common stock. The shares were issued under an at-the-market equity offering program tied to an effective Form S-3 shelf registration statement and an April 8, 2026 prospectus supplement.
What registration statement did Aehr Test Systems (AEHR) use for the $60.0M stock sales?
The company used an effective Form S-3 registration statement, File No. 333-282661, which registered up to $100.0 million of securities. The at-the-market common stock sales for approximately $60.0 million were conducted under this shelf and a related prospectus supplement.
What type of offering did Aehr Test Systems (AEHR) complete for the $60.0M raise?
Aehr Test Systems completed an at-the-market equity offering program, selling newly issued common stock directly into the market. This flexible structure allowed the company to place shares over time under its Form S-3 shelf registration and an April 8, 2026 prospectus supplement.
When did Aehr Test Systems (AEHR) report completing its at-the-market program?
The company reported that on April 17, 2026, it had fully utilized its previously announced at-the-market equity offering program. By that date, Aehr Test Systems had completed common stock sales generating aggregate gross proceeds of approximately $60.0 million under its Form S-3 shelf registration.